RadioPharmaceutical Characterization Laboratory (RPCL) of Institute of Nuclear Energy Research (INER) has been devoting to develop chemical analysis and identification of structures techniques based o
Objective: Carcinoma of unknown primary (CUP) represents a heterogeneous group of metastatic malignancies for which primary tumor site could not be identified after routine diagnostic methods.
Background: During the past half century,rapid advances in biomedical technology,especially with regards to imaging,have revolutionized the approach to diagnosis and treatment of diseases.
Background: Radioiodine-131 (I-131) tiherapy has been commonly used for well differentiated thyroid cancer (DTC).To achieve sufficient I-131 uptake in residual thyroid tissues and tumors,I-131 therapy
Background: Hepatocellular carcinoma (HCC) is the third leading cause of cancer death worldwide.Since expression levels of some molecules may be much higher in tumor cells than in normal tissues,trace
Background: For brain SPECT/CT,although CT images provide precise anatomical information and accurate attenuation correction,their use increases the radiation dose to the patient,especially to the eye
Purpose: In Japan,only cardiac lesion is under insurance coverage in sarcoidosis.The aim of this study was to investigate detect ability of 18F-FDG PET/CT for sarcoidosis activity other than cardiac l